Form 4 for ABBV AbbVie
Accepted 2024-09-30 00:00:00 ET · period of report 2024-09-24 · accession 0001415889-24-024096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 2024-09-24 | ABBV | SALEKI-GERHARDT AZITA | EVP, Chief Ops Off | G - Gift | $0.00 | -25.6K | 194.3K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2024-09-24 | G | D | 25,630 | $0.00 | 194,348 | D | — | — |